Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinoma.

Saved in:
Bibliographic Details
Title: Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinoma.
Authors: Jaime-Casas S; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Barragan-Carrillo R; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Zugman M; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Shah K; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Ebrahimi H; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Mercier B; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Castro DV; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Zang PD; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., LeVee A; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Yip W; Division of Urology and Urologic Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Li X; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Dizman N; Department of Hematology and Oncology, MD Anderson Cancer Center, Houston, TX, United States., Salgia NJ; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States., Zengin Z; Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States., Meza L; Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States., Hsu J; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Nguyen CB; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Chehrazi-Raffle A; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Pal SK; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States., Tripathi A; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.
Source: Frontiers in oncology [Front Oncol] 2025 Oct 07; Vol. 15, pp. 1669526. Date of Electronic Publication: 2025 Oct 07 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41127009
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jaime-Casas+S%22">Jaime-Casas S</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Barragan-Carrillo+R%22">Barragan-Carrillo R</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Zugman+M%22">Zugman M</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Shah+K%22">Shah K</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Ebrahimi+H%22">Ebrahimi H</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Mercier+B%22">Mercier B</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Castro+DV%22">Castro DV</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Zang+PD%22">Zang PD</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22LeVee+A%22">LeVee A</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Yip+W%22">Yip W</searchLink>; Division of Urology and Urologic Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Dizman+N%22">Dizman N</searchLink>; Department of Hematology and Oncology, MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Salgia+NJ%22">Salgia NJ</searchLink>; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States.<br /><searchLink fieldCode="AU" term="%22Zengin+Z%22">Zengin Z</searchLink>; Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States.<br /><searchLink fieldCode="AU" term="%22Meza+L%22">Meza L</searchLink>; Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, United States.<br /><searchLink fieldCode="AU" term="%22Hsu+J%22">Hsu J</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Nguyen+CB%22">Nguyen CB</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Chehrazi-Raffle+A%22">Chehrazi-Raffle A</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Pal+SK%22">Pal SK</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.<br /><searchLink fieldCode="AU" term="%22Tripathi+A%22">Tripathi A</searchLink>; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2025 Oct 07; Vol. 15, pp. 1669526. <i>Date of Electronic Publication: </i>2025 Oct 07 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41127009
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2025.1669526
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1669526
    Titles:
      – TitleFull: Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jaime-Casas S
      – PersonEntity:
          Name:
            NameFull: Barragan-Carrillo R
      – PersonEntity:
          Name:
            NameFull: Zugman M
      – PersonEntity:
          Name:
            NameFull: Shah K
      – PersonEntity:
          Name:
            NameFull: Ebrahimi H
      – PersonEntity:
          Name:
            NameFull: Mercier B
      – PersonEntity:
          Name:
            NameFull: Castro DV
      – PersonEntity:
          Name:
            NameFull: Zang PD
      – PersonEntity:
          Name:
            NameFull: LeVee A
      – PersonEntity:
          Name:
            NameFull: Yip W
      – PersonEntity:
          Name:
            NameFull: Li X
      – PersonEntity:
          Name:
            NameFull: Dizman N
      – PersonEntity:
          Name:
            NameFull: Salgia NJ
      – PersonEntity:
          Name:
            NameFull: Zengin Z
      – PersonEntity:
          Name:
            NameFull: Meza L
      – PersonEntity:
          Name:
            NameFull: Hsu J
      – PersonEntity:
          Name:
            NameFull: Nguyen CB
      – PersonEntity:
          Name:
            NameFull: Chehrazi-Raffle A
      – PersonEntity:
          Name:
            NameFull: Pal SK
      – PersonEntity:
          Name:
            NameFull: Tripathi A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 10
              Text: 2025 Oct 07
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1